Dr S Manivannan, Deputy Drugs Controller (India), Central Drugs Standard Control Organisation (CDSCO), has now taken additional charge of sub-zone Bengaluru . He will oversee the exports and imports of drugs in Karnataka and also monitor the ... PharmaBiz, 1 day ago
Why CDSO's scheme to crack down on fake drugs may not work - Moneycontrol.com, 1 month ago
CDSCO issues slew of notices on clinical trials, drug safety - Express Pharma, 2 months ago
1 images for "dcgi"
The Drug Controller General of India (DCGI) has approved marketing and manufacturing of Remicade (infliximab) biosimilar BOW015 of EPIRUS Biopharmaceuticals, Inc., a Boston-based biopharmaceutical company focused on the global development and ...PharmaBiz, 4 days ago Epirus gets DCGI nod for arthritis drug biosimilar Business Standard, 4 days ago DCGI bars Pregna Intl from manufacturing medical device 'Tcu 380Ag' in6 violation of D&C Act PharmaBiz, 1 month ago EPIRUS Biopharmaceuticals' Remicade Biosimilar Gets Final Approvals in India Individual.com, 3 days ago
More from: Stock Nod, Stock Nod...and 35 other sources
Aiming to address woes of the exporters on a fast track basis, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) has urged the commerce ministry to push for more high level interaction between the stakeholders, Drug Controller ...PharmaBiz, 2 days ago TROUBLE WORSENING FOR EXPORTERS PharmaBiz, 1 week ago Pharmexcil to celebrate 10th annual meet with host of events Express Pharma, 1 month ago Pharmaceuticals Export Promotion Council recommends two more seaports for exports Economic Times, 1 month ago
Singapore: India's Chennai-based Nichi-In Center for Regenerative Medicine has been by the DCGI, to stop selling the Dendriatic cell cancer vaccine for Dendriatic immunization therapy. The controller has also issued a safety alert against the use of ...Bio Spectrum Asia, 1 week ago DCGI orders Nichi-In to stop sale of Dendriatic cell cancer vaccine in name of Dendriatic cell immunotherapy PharmaBiz, 1 week ago DCGI ban on DC therapy for cancer Asian Age, 1 month ago DCGI issues safety alert against use of Dendriatic cells for treatment of cancer PharmaBiz, 1 month ago
As per the recommendations of the Prof Ranjit Roy Choudhury committee, the Drugs Controller General of India (DCGI) has renamed new drug advisory committees (NDACs) as subject expert committees (SECs). Prof Ranjit Roy Choudhury committee was ...PharmaBiz, 3 weeks ago DCGI sets up Independent Expert Committee for examination of reports of SAEs occurred during trials PharmaBiz, 1 month ago
Sun Pharma and Ranbaxy Labs gained 3-3.5 percent after sources said Drug Controller General Of India (DCGI) reinstated European Union export licence to Ranbaxy's Toansa unit. DCGI had suspended supply from that unit to EU in May.Money Control, 2 weeks ago
The Association of Biotechnology Led Enterprises (ABLE), and the Association of Contract Research Organisations (ACRO) India have cautioned the DCGI to preserve confidentiality of the patients. The industry bodies have also requested to retain the ...PharmaBiz, 3 weeks ago Keep clinical trial services out of service tax ambit: ABLE Business Standard India, 3 weeks ago 'Keep clinical trial services out of service tax ambit' Economic Times, 3 weeks ago
NAGPUR: The Maharashtra Food and Drug Administration (FDA) has written to the Drug Controller General of India (DCGI) to seek CBI intervention in the issue of what the FDA claims is smuggling of drugs to and fro from India through websites. The ...Times of India, 1 month ago Maha FDA writes to NPPA to bring medical devices under DPCO to curb profiteering PharmaBiz, 2 months ago
Supreme Court has asked the DCGI and the ICMR on how they have issued licenses for the experimental use of vaccines for cervical cancer. Reuters Questioning the way seven tribal girls died while they were being given experimental treatment for ...International Business Times India, 1 month ago
Centre insistence on 6 months time frame for trial approvals by DCGI helps to pick up clinical research in India
Union government has taken steps to prove its support to the pharma, biotech and clinical trial companies by insisting that approval of clinical trials from the Drugs Control General of India's (DCGI) office should be granted within six months. The ...PharmaBiz, 2 months ago DCGI directs clinical trial sponsors & cos to give compensation in drug-related anomaly discerned later PharmaBiz, 2 months ago Health ministry makes inclusion of 3 parameters mandatory in clinical trial applications PharmaBiz, 1 week ago
on your WebpageAdd Widget >Get your members hooked!